Slide 1: Financial Results for FY2021 Q3
Financial Results for FY2021 Q3 Ended September 30, 2021 November 10, 2021 Junya Suzuki President and CEO Nissha Co., Ltd.
Slide 2: Highlights
Highlights FY2021 Q3 Results (9 months ended) ⚫ Significant increase in profit YoY (1USD=JPY107) ⚫ Net sales 145.5 billion yen, Operating profit 15.4 billion yen, Profit before tax 16.9 billion yen, Profit attributable to owners of parent 14.5 billion yen ⚫ Industrial Materials: Strong product deman
Slide 3: FY2021 Q3 (9 months) Results
FY2021 Q3 (9 months) Results ⚫ Steady demand for main three businesses ⚫ Significant increase in profit due to the equalization of production volumes and improvement of profit structure (Millions of JPY) （百万円） FY2020 FY2021 Q3 (Jan.-Sep.) Q3 (Jan.-Sep.) YoY Results Results Net sales 128,785 145,532
Slide 4: FY2021 Q3 (3 months) Results
FY2021 Q3 (3 months) Results ⚫ Achieved an increase in profit despite a decrease in net sales YoY due to the demand decline for smartphones. (Millions of JPY) FY2020 FY2021 FY2021 Q3 Q2 Q3 (Jul.-Sep.) (Apr.-Jun.) (Jul.-Sep.) YoY QoQ Results Results Results Net sales 51,620 50,444 47,948 -7.1% -4.9%
Slide 5: Industrial Materials
Industrial Materials ⚫ Strong product demand continued for both decoration and sustainable materials YoY. (Millions of JPY) Net sales trend by ■ ■Sustainable Materials (Metalized paper) application (by quarter) ■ ■Decoration (Others) 20,000 ■ ■Decoration (Mobility (Automotive/Transport equipment)) 1
Slide 6: Devices
Devices ⚫ Equalization of production volumes continued. ⚫ Q3: Product demand for tablet devices was strong, while that for smartphones decreased. (Millions of JPY) Net sales trend by ■ ■Potable game players, Industrial equipment (logistics related) , Mobility (Automotive/Transport equipment), Gas se
Slide 7: Medical Technologies
Medical Technologies ⚫ Recovery trend from COVID-19 continued. Net sales trend by ■ ■ Business media (Millions of JPY) application (by quarter) ■ ■ Medical devices (Own brand) ■ ■ Medical devices (CDMO) 7,500 6,098 6,266 5,700 5,213 5,411 5,068 5,000 4,586 2,500 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY2020 FY2021
Slide 8: Full-year forecast remains unchanged
Full-year forecast remains unchanged ⚫ Breakdown by business for operating profit was adjusted. ⚫ Reflected the profitability improvement in Devices and the rising costs of raw materials and labor in Medical Technologies. (Millions of JPY) FY2021 FY2021 FY2020 Full-year Full-year Full-year YoY Previ
Slide 9: Revision of dividend forecast
Revision of dividend forecast ⚫ Special dividend (10 yen) is planned based on the progress of business results for the current fiscal year. ⚫ Annual dividend 40 yen: Ordinary dividend 30 yen + Special dividend 10 yen Annual dividends per share (yen) Ordinary dividend (Interim dividend) Ordinary divi
Slide 10: Reference: Capital investment, Depreciation and amortization, M&A investment, R&D
Reference: Capital investment, Depreciation and amortization, M&A investment, R&D (Millions of JPY) Q1 Q2 Q3 (Jan.-Mar.) (Apr.-Jun.) (Jul.-Sep.) Results Results Results Capital 1,038 3,068 1,203 investment Depreciation and 2,314 2,309 2,296 amortization M&A investment ｰ ｰ ｰ R&D 677 714 721 ©2021 Nis
Slide 11: Among the information included in this presentation and provided at investor briefings and conferences,
Among the information included in this presentation and provided at investor briefings and conferences, performance targets, plans, outlooks, strategies and other information that is not constituted of actual past facts, is information that has been judged reasonable by the managers of the Company b